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Supplementary Methods: Patient management during study periods
Perioperative therapy for hemodynamic management and monitoring for OPCAB were conducted in the institutional standard manner. All preoperative medications, except for antiplatelet agents, diuretics, angiotensin-converting enzyme inhibitors, and angiotensin II receptor blockers, were continued until the morning of surgery. Before the induction of general anesthesia, an intra-arterial catheter was inserted into the radial artery under local anesthesia. A central venous catheter (MAC TM , Arrow International Inc, Reading, PA, USA) and a pulmonary artery catheter (Swan-Ganz CCombo ® V CCO/SvO 2 /CEDV Thermodilution Catheter, Edwards Lifesciences LLC, Irvine, CA, USA) were inserted through the right internal jugular vein. Using a Vigilance ® monitor (Edwards Lifesciences LLC, Irvine, CA, USA), cardiac output and mixed venous oxygen saturation were continuously measured, as were five-lead electrocardiography, pulse oxymetry, capnography, and urine output. Core temperature was kept above 36.0°C using a forced-air warming system.
During both study periods, the goals of anesthetic management during OPCAB were to maintain hemodynamic stability (mean arterial pressure > 65 mmHg, heart rate > 60 beats/min, central venous pressure of 8-12 mmHg, pulmonary capillary wedge pressure of 12-15 mmHg, urine output > 0.5 ml/kg/h, cardiac index > 2.0 L/min/m 2 , and mixed venous oxygen saturation > 70%). Standard hemodynamic management for OPCAB included mainly fluid administration to achieve normovolemia and preset hemodynamic goal in addition to vasopressors or inotropes to prevent excessive fluid administration. 
